Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
522.00    -3.00 (-0.57%)
Bid:
524.00
Ask:
526.00
Spread: 2.00 (0.382%)
Market Cap: £512.62m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Trading Statement

21 Jan 2026 07:00

RNS Number : 6610P
Galliford Try Holdings PLC
21 January 2026
 

Galliford Try Holdings plc

Trading Update

Wednesday 21 January 2026

 

 

Continued progression in H1 and increased confidence in full year delivery

 

Galliford Try Holdings plc, a leading FTSE 250 construction group, today provides an update on trading for the half year from 1 July 2025 to 31 December 2025. The Group expects to announce its results for the half year on Wednesday 4 March 2026.

 

Update on Current Trading

 

The Group's businesses are performing well, with trading ahead of the prior year, and the Board's expectations. Our strong market position in our chosen sectors and extensive participation in national long-term frameworks - particularly in transportation, education, defence, custodial and health - is well aligned with the Government's future spending plans. The significantly enlarged AMP8 water framework programmes are progressing in line with expectations.

Given the outlook, we now expect revenue for the full financial year to be towards the upper end of current market expectations and for adjusted profit before tax to be slightly above the top end of current market expectations.1

1 The range of analysts' forecasts for the year ending 30 June 2026, based on forecasts at 19 January 2026, is for revenue of £1,900m to £1,922m and adjusted profit before tax of £46.8m to £47.7m.

 

Balance Sheet

 

The average month-end cash for the rolling 12 months ended 31 December 2025 was £189.9m (year to 30 June 2025: £178.7m) and period-end cash at 31 December 2025 was £211.7m (31 December 2024: £210.0m). The Group continues to maintain a portfolio of PPP assets and has no debt or pensions liabilities.  The Group's revolving credit facility, established last year, remains undrawn.

 

We believe the Group's strong balance sheet differentiates our ability to secure high quality contracts and frameworks, to attract a highly skilled supply chain and continue to invest in the business whilst providing incremental returns to shareholders.

 

Share Buyback

 

On 17 September 2025, the Group launched its third share buyback programme of up to a maximum of £10.0m. As at 19 January 2026 the Group had purchased a total of 1,579,151 shares, for an aggregate consideration of £8.0m.

 

Order Book and Outlook

 

Our order book of £4.1bn (31 December 2024: £3.9bn) is predominantly in long-term frameworks providing high visibility of future workload. We continue to see a strong pipeline of medium and long-term opportunities across our chosen sectors, supported by our track record and focus on the public and regulated sectors alongside high-quality private clients.

 

Since the start of the financial year the Group's notable framework wins include:

 

- a place on National Grid's £9.0bn Major Works & Civils Framework, Lot 1 - Converter Civils & Buildings, as part of the HVDC programme,

- a place on the £3.0bn affordable homes framework across the East, South and London regions for the Registered Provider, The Hyde Group, and

- reappointment to the £1.0bn YORCivil Major Works 2 Framework.

 

 

Bill Hocking, Chief Executive, commented:

 

"We are pleased with our recent framework and project wins as well as the opportunities we continue to see across all our chosen sectors. The Group benefits from having a strong balance sheet and a high-quality carefully selected order book, and our ongoing investment in our excellent people continues to build strong project teams to consistently deliver for our clients. 

 

The Group's businesses have performed well in the first half, supporting further confidence in delivering strong results in the current financial year. We remain focussed on driving long-term value creation for all our stakeholders as we deliver our Sustainable Growth Strategy to 2030."

 

 

For further enquiries please contact:

 

Galliford Try

Bill Hocking, Chief Executive

Kris Hampson, Chief Financial Officer

Kevin Corbett, General Counsel & Company Secretary

01895 855001

Teneo 

James Macey White/Ffion Dash

 

020 7260 2700

 

The person responsible for making this announcement on behalf of Galliford Try is Kevin Corbett, General Counsel & Company Secretary.

 

Note to Editors

Galliford Try is a trading name of Galliford Try Holdings plc, a leading FTSE 250 UK construction group. Operating as Galliford Try and Morrison Construction, the group carries out building and infrastructure (environment and highways) projects with clients in the public, private and regulated sectors across the UK.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBLGDBUSDDGLG
Date   Source Headline
12th Sep 20187:00 amRNSFinal Results
4th Sep 201810:00 amRNSHolding(s) in Company
3rd Sep 20189:00 amRNSConfirmation of Directorate Change
21st Aug 201812:00 pmRNSHolding(s) in Company
1st Aug 20182:00 pmRNSTotal Voting Rights
24th Jul 20184:00 pmRNSHolding(s) in Company
19th Jul 201811:00 amRNSDirectorate Change
17th Jul 20187:00 amRNSTrading Statement
11th Jul 201812:00 pmRNSHolding(s) in Company
2nd Jul 201812:00 pmRNSTotal Voting Rights
27th Jun 20182:00 pmRNSBlock listing Interim Review
7th Jun 201810:00 amRNSDirector/PDMR Shareholding
5th Jun 20182:00 pmRNSDirector/PDMR Shareholding
1st Jun 201812:00 pmRNSTotal Voting Rights
25th May 201812:00 pmRNSDirector/PDMR Shareholding
22nd May 20187:00 amRNSTrading Statement
9th May 20184:00 pmRNSHolding(s) in Company
1st May 20184:00 pmRNSTotal Voting Rights
18th Apr 201812:00 pmRNSTotal Voting Rights
16th Apr 20183:15 pmRNSDirector/PDMR Shareholding
16th Apr 20182:43 pmRNSSuccessful Placing of Rights Issue Rump
16th Apr 20188:15 amRNSTotal Voting Rights
16th Apr 20187:25 amRNSResults of Rights Issue
9th Apr 20184:30 pmRNSDirector/PDMR Shareholding
6th Apr 20184:30 pmRNSHolding(s) in Company
6th Apr 201810:00 amRNSHolding(s) in Company
5th Apr 201810:30 amRNSDirector/PDMR Shareholding
3rd Apr 20184:00 pmRNSDirector/PDMR Shareholding
3rd Apr 20184:00 pmRNSDirector/PDMR Shareholding
3rd Apr 201811:00 amRNSHolding(s) in Company
3rd Apr 201811:00 amRNSTotal Voting Rights
28th Mar 20182:30 pmRNSDirector/PDMR Shareholding
28th Mar 201811:00 amRNSDirector/PDMR Shareholding
27th Mar 20181:11 pmRNSPublication of Prospectus
27th Mar 20187:00 amRNSAnnouncement re: Rights Issue
20th Mar 201810:00 amRNSHolding(s) in Company
1st Mar 201812:00 pmRNSTotal Voting Rights
1st Mar 201810:00 amRNSHolding(s) in Company
14th Feb 20187:00 amRNSFully Underwritten £150 million Capital Raising
14th Feb 20187:00 amRNSHalf-year Report
5th Feb 201810:00 amRNSHolding(s) in Company
1st Feb 201812:00 pmRNSTotal Voting Rights
15th Jan 201811:04 amRNSJoint Venture with Carillion plc
2nd Jan 201812:00 pmRNSTotal Voting Rights
5th Dec 20173:00 pmRNSBlock Listing Application
4th Dec 201710:00 amRNSHolding(s) in Company
1st Dec 201712:00 pmRNSTotal Voting Rights
27th Nov 201712:00 pmRNSBlock listing Interim Review
17th Nov 201710:00 amRNSHolding(s) in Company
16th Nov 20177:00 amRNSContract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.